Log in

Relevant bibliographies by topics / Anti-emetic drugs

Contents

Journal articles
Dissertations / Theses
Books
Book chapters

Academic literature on the topic 'Anti-emetic drugs'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-emetic drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-emetic drugs"

1

Damian, G. "EPR investigation of γ-irradiated anti-emetic drugs." Talanta 60, no. 5 (July 27, 2003): 923–27. http://dx.doi.org/10.1016/s0039-9140(03)00153-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Matsuki, Norio. "Development of Anti-Emetic and Anti-Motion Sickness Drugs using Suncus murinus." Japanese Journal of Pharmacology 55 (1991): 38. http://dx.doi.org/10.1016/s0021-5198(19)38153-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zhang, W., J. R. Zalcberg, and W. Cosolo. "Interaction of epirubicin with other cytotoxics and anti-emetic drugs." Anti-Cancer Drugs 3, no. 6 (December 1992): 593–98. http://dx.doi.org/10.1097/00001813-199212000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Markl, Gertraud E., Chirstine Strunz-Lehner, Veronika Egen-Lappe, and Joerg Hasford. "Prescribing patterns of anti-emetic drugs during pregnancy in Germany." Archives of Gynecology and Obstetrics 275, no. 6 (November 29, 2006): 461–67. http://dx.doi.org/10.1007/s00404-006-0286-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Horn, Charles C. "Is there a need to identify new anti-emetic drugs?" Drug Discovery Today: Therapeutic Strategies 4, no. 3 (September 2007): 183–87. http://dx.doi.org/10.1016/j.ddstr.2007.09.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Perwitasari, D. A., Hans Gelderblom, Jarir Atthobari, Mustofa Mustofa, Iwan Dwiprahasto, Johan W. R. Nortier, and Henk-Jan Guchelaar. "Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics." International Journal of Clinical Pharmacy 33, no. 1 (January 28, 2011): 33–43. http://dx.doi.org/10.1007/s11096-010-9454-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zhang, Fang. "Value of mink vomit model in study of anti-emetic drugs." World Journal of Gastroenterology 12, no. 8 (2006): 1300. http://dx.doi.org/10.3748/wjg.v12.i8.1300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ritchie, Helen E., Isabelle Broström Huss, and William S. Webster. "The effect of anti-emetic drugs on rat embryonic heart activity." Reproductive Toxicology 87 (August 2019): 140–45. http://dx.doi.org/10.1016/j.reprotox.2019.06.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Wilkinson, David J. "Day-case surgery, anti-emetic drugs and the history of anaesthesia." Current Opinion in Anaesthesiology 4, no. 6 (December 1991): 799–804. http://dx.doi.org/10.1097/00001503-199112000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

King, A. G. "Complete rescue from established emesis by the NK-1 receptor antagonist, casopitant mesylate, in cisplatin-induced delayed emesis in the ferret." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 18601. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.18601.

Full text

Abstract:

18601 Background: Postoperative and chemotherapy-induced nausea and vomiting (PONV, CINV) can be major complications in patients undergoing surgery or cancer treatment with emetogenic drugs. Nausea and vomiting may extend beyond the postoperative recovery period or in a delayed manner following chemotherapy. Prophylaxis with 5-HT3 receptor antagonists may fail in some patients, requiring the use of rescue medications. Selective NK-1 receptor antagonists provide incremental improvement in efficacy when used in combination with 5-HT3 antagonists and dexamethasone, both in preclinical animal models and in the clinical setting. Methods: The anti-emetic and anti-nausea properties of a potent and selective NK-1 receptor antagonist, casopitant mesylate ( GW679769 ), were evaluated in the ferret using single-dose rescue treatment in a cisplatin-based delayed emesis model. In the delayed model (72 hr), a single dose of saline, ondansetron, or casopitant mesylate was administered ip at 44.8 hrs post cisplatin (5 mg/kg, ip). This time corresponds to peak emetic frequency in this model. Results: Ondansetron (1 mg/kg) significantly delayed further emetic events for ∼8 hours post injection. Emetic frequency after this latency period then paralleled the saline treated group. In contrast, casopitant mesylate resulted in an immediate dose-dependent rescue from further emetic events, with minor effects on latency. Complete rescue from further emetic events were achieved at casopitant mesylate doses ≥0.5 mg/kg. Casopitant mesylate rescue treatment also reduced nausea-like behaviors in a dose-dependent manner; however, higher doses were required to achieve statistical significance. Conclusions: Single-dose ondansetron rescue treatment failed to reduce nausea-like behaviors. These unique results, along with previously described anti-emetic prophylactic activity, support the ongoing clinical evaluation of casopitant mesylate, which is currently in phase III trials for the prevention of PONV and CINV from moderately and highly emetogenic chemotherapy. It is also in clinical development for depression and anxiety. [Table: see text]

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Anti-emetic drugs"

1

Reynolds, David John Morton. "Functional anatomy and neuropharmacology of emesis." Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.335848.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Dodson, N. J. "New annelation methods for nitrogen heterocycles." Thesis, University of Bath, 1987. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.377591.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Anti-emetic drugs"

1

J, Gralla R., ed. Serotonin and the scientific basis of anti-emetic therapy. [Berlin]: Springer Verlag, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Reynolds, D. J. M., P. L. R. Andrews, and C. Jserotonin Davis. Serotonin and the Scientific Basis of Anti-emetic Therapy. Hodder Arnold, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

M, Reynolds D. J., Andrews P. L. R, Davis C. J. 1950-, and Oxford Clinical Communications, eds. Serotonin and the scientific basis of anti-emetic therapy. Oxford: Oxford Clinical Communications, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Anti-emetic drugs"

1

Herling, Andreas W. "Emetic and Anti-Emetic Activity." In Drug Discovery and Evaluation: Pharmacological Assays, 2469–78. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-05392-9_58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

"How anti-emetic drugs work." In How Drugs Work, 100–101. CRC Press, 2017. http://dx.doi.org/10.1201/9781315385020-17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"Nausea and vomiting." In Oxford Handbook of Cancer Nursing, edited by Mike Tadman, Dave Roberts, Mark Foulkes, Mike Tadman, Dave Roberts, and Mark Foulkes, 531–38. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198701101.003.0044.

Full text

Abstract:

Nausea and vomiting are common and distressing symptoms of cancer and its treatments. Treatment-related nausea and vomiting are covered in depth, including pre-treatment assessment, the emetogenic level of chemotherapy drugs, and pharmacological management of chemotherapy-induced nausea and vomiting. An evidence-based treatment algorithm is described, covering the wide range of possible anti-emetics. Non-pharmacological options are also described. There is also a section on anticipatory nausea and vomiting. Nausea and vomiting in advanced cancer are covered separately. The multifactorial nature of this is discussed, with a focus on different anti-emetic regimes, as well as nursing management, including detailed assessment and ongoing nutritional and psychological support.

APA, Harvard, Vancouver, ISO, and other styles

4

"20 Anti-emetic assay." In Bioassay Techniques for Drug Development, 110. CRC Press, 2001. http://dx.doi.org/10.3109/9780203304532-27.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Selvasudha, Nandakumar, Unnikrishnan-Meenakshi Dhanalekshmi, Sekar Krishnaraj, Yogeeswarakannan Harish Sundar, Nagarajan Sri Durga Devi, and Irisappan Sarathchandiran. "Multifunctional Clay in Pharmaceuticals." In Clay Science and Technology [Working Title]. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.92408.

Full text

Abstract:

Clay has its widespread applications in pharmaceuticals from ancient world to modern era. It is one of the excellent excipients present in the commercially available pharmaceuticals. Its use in many of dosage forms viz. in suspension, emulsion, ointments, gels, tablet and as drug delivery carrier as suspending agent, emulsifying agent, stiffening agent, binder, diluent, opacifier, and as release retardant have been explored in many studies. Variety of minerals is used as both excipient and as an active ingredient; among that kaolinite, talc, and gypsum are important. Their inertness, low toxicity, versatile physiochemical properties and cost effectiveness has increased its usage in pharma industries. Many minerals have its own pharmacological action as antacid, anti-bacterial, anti-emetic, anti- diarrheal agent and as skin protectant etc. Their unique structure which helps them to absorb material onto their layered sheets has opened a wide variety of applications in drug delivery. The understanding of surface chemistry and particle size distribution of clay minerals has led the pharmaceutical field in many directions and future perspectives.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!